Flu vs COVID vs RSV: Telling the Three Apart by Symptoms and Tests

A mother in a pharmacy aisle, two feverish children in the cart, holding a small box that promises to check for flu A, flu B and COVID-19 from a single nasal swab. Five years ago that box did not exist. As of October 2025, it sits beside the tissues, and it is one reason the phrase flu vs covid is climbing the search charts again.

The other reason is quieter. Respiratory syncytial virus, long treated as a nursery problem, now has its own vaccines for pregnant women and older adults, plus long-acting antibody protection for infants. The three viruses that fill emergency departments every winter finally have three sets of tools, and people want to know which illness they are actually fighting.

That question matters more than it used to. The right antiviral works best in the first two days, the right vaccine depends on your age and risk, and the right amount of worry depends on which virus is behind the cough. This piece walks through what the evidence shows, how strong that evidence is, and where the honest answer is still “get swabbed.”

What changed recently in the flu vs COVID vs RSV picture

Three developments explain the surge of interest, and each is dated and documented by public health agencies.

First, testing. Combination at-home tests that detect influenza A, influenza B and SARS-CoV-2 (the virus that causes COVID-19) from one swab were authorized by the US Food and Drug Administration during 2023 and 2024 and are now widely stocked. Before that, a home test could tell you about COVID-19 only, which left flu as a guess.

Second, RSV prevention. The CDC recommends a single RSV vaccine dose for all adults aged 75 and older, and for adults aged 50 to 74 who are at increased risk of severe RSV disease, a group widened in 2025 from the original 60-and-over threshold set in 2023. Pregnant women can receive an RSV vaccine at 32 to 36 weeks of pregnancy during the September-to-January window so antibodies pass to the baby, and infants under eight months entering their first RSV season can receive a long-acting monoclonal antibody, a laboratory-made immune protein that gives passive protection for months. The CDC RSV vaccine pages linked in the references carry the current eligibility wording.

Third, the way clinicians talk about COVID-19 has shifted. The CDC’s updated comparison of flu and COVID-19 now describes a shorter typical incubation period for COVID-19 than in 2020, usually 2 to 5 days with current variants, which narrows one of the old distinguishing features between the two illnesses.

None of these changes alters the basic clinical truth: fever, cough and exhaustion look alike whether the cause is influenza, coronavirus or RSV. What they change is how much you can learn, and how quickly, once you decide to find out.

Flu vs COVID vs RSV: three viruses, one overlapping set of symptoms

Think of these illnesses as three different burglars who all leave through the same window. Influenza viruses (types A and B cause nearly all human flu) infect the lining of the nose, throat and lungs and trigger a strong inflammatory response, which is why flu is famous for the “hit by a truck” feeling. SARS-CoV-2 enters cells through a receptor called ACE2 that is present in the airways but also in blood vessels, gut and nerves, which helps explain COVID-19’s wider menu of symptoms, from diarrhea to lost smell. RSV, respiratory syncytial virus, favors the smallest airways, the bronchioles, where swelling and thick mucus produce the wheeze that characterizes it in babies and frail adults.

All three spread mainly by respiratory droplets and aerosols, the fine particles exhaled with breathing, talking and coughing. All three cause fever, cough, runny or stuffy nose, sore throat, fatigue and headache. All three can progress to pneumonia, an infection that fills the air sacs of the lungs with fluid.

Scale differs. The CDC estimates that flu causes between 9 and 41 million illnesses and 140,000 to 710,000 hospitalizations in the United States in a typical season. RSV leads to roughly 58,000 to 80,000 hospitalizations a year among children under five and 100,000 to 160,000 among adults 65 and older. COVID-19 hospitalizations have fallen sharply since 2021 but still exceed flu’s in many weeks of the year, particularly among adults over 65.

Here is the one opinion worth holding firmly: the overlap is the point. Anyone who tells you they can reliably name the virus from the sound of a cough is guessing, and the data say so.

COVID symptoms vs flu symptoms: what the first 48 hours can tell you

The onset pattern is the most useful clinical clue, though it is a tendency rather than a rule.

Flu typically arrives abruptly. People often remember the hour they fell ill: fine at lunch, shivering by dinner, with fever of 100.4°F (38°C) or higher, pounding head, aching muscles and a dry cough. Runny nose and sneezing are less prominent in adults with flu than in a common cold, which is one reason flu feels less like “a cold” and more like being unwell all over. The NHS notes that flu symptoms come on very quickly and usually peak within two to three days.

COVID-19 more often builds gradually. A scratchy throat and headache on day one, congestion and fatigue on day two, a cough and fever that follow. With the variants circulating since 2022, sore throat, hoarseness, nasal congestion and headache are among the most commonly reported early symptoms, while the hallmark loss of taste or smell that defined 2020 now affects a minority of patients, according to Mayo Clinic and CDC summaries. Gastrointestinal upset, diarrhea and nausea, occurs in a meaningful share of COVID-19 cases and is less typical of flu in adults.

Timing of exposure helps too. Flu’s incubation period, the gap between infection and first symptoms, runs 1 to 4 days. COVID-19 with current variants is usually 2 to 5 days but can stretch longer. If a household member tested positive for flu four days ago and you have just developed a sudden fever, flu is the stronger bet; if the gap is a week, COVID-19 becomes more plausible.

Treat these as odds, not verdicts. Studies comparing symptom lists in emergency departments repeatedly find that no single symptom, and no simple combination, reaches the accuracy a swab provides.

RSV vs COVID symptoms: where wheezing, babies and the over-65s come in

RSV behaves differently depending on who catches it, and age is the deciding factor.

Healthy school-age children and adults usually experience RSV as a heavy cold: congestion, runny nose, mild cough, low-grade fever, lasting one to two weeks. Infants tell a different story. In babies under one year, especially under six months, RSV is the leading cause of bronchiolitis, an inflammation of the smallest airways that produces wheezing, fast breathing, flaring nostrils and difficulty feeding. Cleveland Clinic and MedlinePlus both describe this picture as the classic RSV presentation in infancy. Very young infants may show no cough at all, only irritability, poor feeding and pauses in breathing.

Adults over 65 and people with heart failure, COPD or weakened immune systems form the second vulnerable group. In them, RSV often triggers a worsening of existing lung or heart disease rather than a dramatic new illness, so the clue is “my usual breathlessness got much worse” more than “I have a fever.”

How does this compare with COVID-19? Both can cause wheeze and shortness of breath, but RSV typically produces more mucus, more audible chest noise and less of the systemic features (headache, body aches, loss of smell, diarrhea) that mark COVID-19. RSV also rarely causes the high, sudden fever of flu.

The incubation period for RSV is 2 to 8 days, most often 4 to 6, slightly longer than flu’s. Contagiousness lasts three to eight days in most people, but infants and immunocompromised adults can shed the virus for up to four weeks, which matters in households with a newborn. Testing for RSV is routine in hospitals and increasingly available in clinics, but it is not yet part of most home test kits.

Side-by-side comparison table: timing, symptoms and contagious window

The table below gathers the typical patterns described by the CDC, Mayo Clinic and NHS. Every row describes what is common, not what is guaranteed; a child with COVID-19 can wheeze, and an adult with RSV can run a high fever.

Feature	Flu (influenza A or B)	COVID-19	RSV
Incubation period	1–4 days	2–5 days typical, up to 14	2–8 days, usually 4–6
Onset	Abrupt, often within hours	Gradual over 1–3 days	Gradual, cold-like first
Fever	Common, often high	Common, variable height	Usually low-grade or absent in adults
Body aches and headache	Prominent	Common, headache frequent	Mild
Sore throat and congestion	Less prominent in adults	Very common with current variants	Congestion and heavy mucus prominent
Loss of smell or taste	Rare	Possible, now a minority	Rare
Wheezing	Uncommon unless asthma	Possible	Hallmark in infants, older adults
Diarrhea or nausea	More common in children	Fairly common in all ages	Uncommon
Contagious before symptoms	About 1 day before	1–2 days before	Yes, briefly
Usual contagious period	5–7 days after onset	Up to about 10 days	3–8 days; weeks in infants
Home test available	Yes, combination kits	Yes	Clinic or hospital test

Two patterns on this grid deserve a second look. Flu’s short incubation and abrupt onset make it the easiest to recognize from a timeline; a known exposure three days ago plus a sudden fever points strongly toward influenza. COVID-19’s sore-throat-first pattern is now the single most common way it announces itself, which is why many people initially mistake it for a cold and only test later.

The last row carries the practical weight. For adults with flu-like illness, a combination home kit can separate the two most likely culprits in about 15 minutes. For infants with wheeze, the decision rests on a clinician’s assessment rather than any home test.

How contagious is flu A compared with COVID-19 and RSV?

Contagiousness is measured two ways: how many people each case infects on average (the basic reproduction number, or R0) and how long an infected person sheds virus.

Influenza A, the type behind most seasonal epidemics and all pandemics, has an R0 of roughly 1.3 in seasonal strains, meaning each case infects a little more than one other person in a population with some existing immunity. That sounds modest, but flu’s short incubation turns it into a fast-moving wave; a single office case can seed a dozen within two weeks. Adults with flu are contagious from about one day before symptoms begin until five to seven days after, and children or immunocompromised adults may shed virus longer.

SARS-CoV-2’s current variants are more transmissible than seasonal flu, with estimates for omicron-lineage viruses in the range of 5 to 10 in immunologically naive populations, though real-world spread is far lower because most people now carry some immunity from infection or vaccination. People with COVID-19 shed the most virus in the day or two before symptoms and the first few days after, and can remain contagious for up to about ten days. That pre-symptomatic window is why COVID-19 was so hard to contain in 2020 and why it still slips through households that wait for a fever before isolating.

RSV’s R0 is estimated at around 3, higher than flu, and it spreads efficiently through contact with contaminated surfaces as well as droplets; the virus survives for hours on hard surfaces and on unwashed hands. Infants often catch it from an older sibling with what looks like a trivial cold.

The practical lesson is consistent across all three: stay home while feverish, mask around vulnerable relatives, and wash hands, because none of these viruses waits for you to feel sick before it moves on.

Why symptoms alone cannot settle flu vs covid: the loss-of-smell problem

In 2020, sudden loss of smell was almost a signature of COVID-19; one large UK symptom-tracking study found it was the single most predictive feature, present in a majority of confirmed cases. That signature has faded. With omicron-lineage variants, Mayo Clinic and CDC descriptions place loss of smell or taste well down the list, reported by a minority of patients, while sore throat and congestion have moved to the top.

This shift illustrates a broader point. The clinical picture of COVID-19 has changed as the virus and the population’s immunity have changed, and it will probably keep changing. Flu, meanwhile, varies by strain and by season; some years H3N2 dominates and hits older adults hard, other years H1N1 or influenza B are more prominent in children. Any list of “distinguishing symptoms” is a snapshot, not a permanent map.

Research bears this out. Studies that tried to build symptom-based scoring tools to separate flu from COVID-19 in emergency departments found moderate accuracy at best; many could not reliably beat a coin toss for individual patients once sore throat and cough were present in both groups. Observational data of this kind consistently show that overlap, not distinction, is the rule.

There are a few features that nudge the probability. Diarrhea, loss of smell and a headache that precedes the cough lean toward COVID-19. Sudden high fever with severe muscle aches leans toward flu. Wheezing in a baby or a frail adult leans toward RSV. But “leans toward” is as far as honest medicine can go.

The constructive conclusion is not to despair of clinical judgment but to use it correctly: symptoms tell you to test and to be careful around others. They do not tell you which antiviral you might need.

Flu covid rsv test options: which swab, when, and how to read a negative

Testing has become the real decider, and knowing the strengths of each kind avoids false reassurance.

Antigen tests detect viral proteins and give a result in 15 to 30 minutes. They are the basis of home kits, including the newer combination kits that report flu A, flu B and COVID-19 separately. Their weakness is sensitivity: antigen tests miss a meaningful share of true infections, particularly in the first day of symptoms when virus levels are still rising. The FDA and CDC advise that a single negative antigen result in someone with symptoms should be repeated after 48 hours before it is trusted.

PCR tests (polymerase chain reaction, a laboratory method that copies and detects the virus’s genetic material) are far more sensitive and remain the reference standard. Clinics and hospitals often run multiplex PCR panels that check for flu, COVID-19 and RSV from the same swab in a few hours. For an older adult or an infant where the result will change treatment, this is the test clinicians prefer.

RSV testing at home is still uncommon, so a negative combination home test leaves RSV unexcluded. In practice that rarely matters for a healthy adult, because RSV in that group is managed with rest and fluids, but it matters a great deal for a wheezing infant or a grandparent with heart failure.

Timing shapes everything. Flu antivirals work best when started within 48 hours of symptom onset, and the oral COVID-19 antiviral options are generally most useful when begun within the first five days, so the moment to test is the first morning you feel unwell, not day four. A positive home result for either virus is highly reliable; a negative one in someone with clear symptoms deserves a second look.

What the evidence actually says, and how strong it is

Grading the evidence helps separate solid ground from reasonable guesswork.

Strong evidence (randomized controlled trials): Flu antivirals shorten illness by roughly a day when started early and reduce complications in high-risk groups; this comes from multiple trials and Cochrane reviews. Oral COVID-19 antivirals reduce hospitalization in unvaccinated high-risk adults, demonstrated in large trials in 2021 and 2022, with smaller or uncertain benefit in vaccinated low-risk people. RSV vaccines for adults 60 and older reduced lower respiratory tract disease by roughly 70 to 85 percent in the phase 3 trials that supported approval, and the infant monoclonal antibody reduced medically attended RSV illness by about 75 percent. Flu vaccination reduces the risk of needing to see a doctor for flu by 40 to 60 percent in seasons where the vaccine matches circulating strains, per CDC effectiveness studies.

Moderate evidence (large observational studies): The symptom profiles described in this article come mainly from cohort and surveillance data. They are reliable for describing populations and much weaker for predicting what one individual has. The finding that COVID-19’s loss-of-smell symptom has become less common is observational but consistent across countries.

Weak or limited evidence (small studies, expert opinion): Most home remedies. Honey for cough in children over one year has small trial support. Saline nasal rinses have modest trial evidence for congestion. Zinc lozenges, vitamin C, elderberry and echinacea have mixed or negative results in systematic reviews; NIH Office of Dietary Supplements fact sheets describe the vitamin C and zinc data as inconclusive for preventing or shortening these infections.

What this grading means in practice: trust testing and vaccination, treat symptom guides as helpful hints, and keep a healthy skepticism about anything sold as a shortcut.

Home remedies for managing flu or COVID symptoms: what actually helps

Most people with flu, COVID-19 or RSV recover at home, and the goal of home care is comfort and safety while the immune system does its work. Nothing on this list shortens the infection meaningfully; these measures manage symptoms.

Fluids come first. Fever and rapid breathing increase water loss, and dehydration worsens headache, fatigue and dizziness. Water, diluted juice, broth and oral rehydration solutions all count. Rest is not a cliché; sleep deprivation measurably blunts immune responses, and pushing through a fever at work mostly spreads the virus.

For fever and aches, over-the-counter fever reducers are reasonable for most adults when used as the package directs; anyone with liver disease, kidney disease, stomach ulcers or who takes blood thinners should ask a pharmacist or clinician which option suits them. Children should never receive aspirin during a viral illness because of the risk of Reye syndrome, a rare but serious swelling of the liver and brain.

Honey, one to two teaspoons, has small randomized trials behind it for night-time cough in children older than one year; it is unsafe for infants under one because of botulism risk. Saline nasal sprays or rinses with sterile water ease congestion with minimal risk. A humidifier or steamy bathroom can loosen mucus, helpful for babies with RSV. Warm liquids soothe a sore throat; so do lozenges in older children and adults.

What does not help: antibiotics (all three illnesses are viral), high-dose vitamin C, zinc megadoses, and the “sweat it out” approach of heavy exercise. The NHS and Mayo Clinic both describe a conservative, comfort-focused approach for uncomplicated cases.

Monitor rather than merely endure. A pulse oximeter, a fingertip device that estimates blood oxygen, is useful in adults with COVID-19 or flu; readings consistently below 92 percent warrant a call to a clinician.

Do over-the-counter cold and flu combination products help with COVID?

People searching whether branded “flu relief” powders and tablets work for COVID-19 are asking a fair question, and the answer is the same for every virus: these products relieve symptoms and do nothing to the virus itself.

Combination cold and flu products typically bundle a fever reducer and pain reliever, a decongestant, a cough suppressant and sometimes an antihistamine into one dose. Each ingredient has evidence for the symptom it targets. A fever reducer lowers temperature and eases aches; a decongestant shrinks swollen nasal blood vessels; a cough suppressant dampens the cough reflex; an antihistamine dries secretions and causes drowsiness. Because COVID-19, flu and RSV all produce these symptoms, the products can make a person with any of the three feel more comfortable for a few hours.

They carry real cautions. Many contain the same fever reducer found in other products, so taking two combination products, or a combination product plus a separate pain reliever, can push the daily total above safe limits; this is one of the most common causes of accidental medication overdose. Decongestants raise blood pressure and heart rate, which matters for people with hypertension or heart disease. Sedating antihistamines impair driving and are not recommended for young children or for older adults at risk of falls. Cough and cold products are not advised for children under four, and many pediatric guidelines extend that to under six.

The honest framing: a combination product is a convenience, not a treatment. For a healthy adult it may make a miserable day tolerable. For anyone at higher risk of complications, or with other prescriptions, a pharmacist’s five-minute check of ingredients and interactions is far more valuable than the product itself. Read the label, use one product at a time, and let the clinician who knows your history guide the choice.

Antiviral medicines for flu and COVID-19: why timing and risk decide

Here is where knowing which virus you have changes what medicine is worth considering, and where every decision belongs to a prescribing clinician.

Prescription antiviral medicines for influenza interfere with the enzyme the virus uses to leave infected cells. Randomized trials show they shorten illness by about a day in otherwise healthy adults when started within 48 hours, and observational data in hospitalized and high-risk patients suggest they reduce complications and death. The CDC recommends that clinicians consider them for people at high risk of flu complications, including adults 65 and older, pregnant women, young children and people with chronic heart, lung, kidney or metabolic disease, and for anyone hospitalized with flu, regardless of how long symptoms have lasted.

For COVID-19, oral antiviral medicines approved for adults at higher risk of severe disease reduced hospitalization substantially in trials conducted in unvaccinated people in 2021 and 2022. Their benefit in vaccinated, lower-risk adults is smaller and, in some studies, not statistically significant. They must be started early, generally within five days of symptom onset, and one of them interacts with a long list of common prescriptions, which is why a clinician’s review is essential rather than a formality.

RSV has no approved antiviral for routine use; management is supportive, meaning oxygen, fluids and breathing support when needed. Prevention through vaccination and infant antibodies is the main medical lever.

Three practical implications follow. Test early, because the clock starts at symptom onset. Tell your clinician every medicine and supplement you take. And do not pressure for an antiviral if you are young, vaccinated and improving; the evidence for benefit in that group is thin, and the clinician’s judgment, not a search result, should set the plan.

Vaccines for flu, COVID-19 and RSV: who is eligible under current guidance

Vaccination is the single intervention with the strongest evidence for keeping all three illnesses out of the hospital, and eligibility differs for each.

Flu. The CDC recommends an annual flu vaccine for everyone aged 6 months and older, with rare exceptions for severe allergy to a vaccine component. Higher-dose or adjuvanted formulations are preferentially recommended for adults 65 and older because trials show better protection in that age group. The NHS offers free flu vaccination to those aged 65 and over, pregnant women, people with certain long-term conditions, young children and health and care workers.

COVID-19. CDC guidance for the 2025 to 2026 season frames updated COVID-19 vaccination for people aged 6 months and older as a decision made in consultation with a healthcare provider, with the clearest benefit for adults 65 and older, people with underlying conditions and those who are pregnant. WHO advises prioritizing older adults, people with comorbidities, pregnant women and health workers. The NHS offers seasonal doses to adults 75 and over, care home residents and people with weakened immune systems.

RSV. The CDC recommends a single dose of RSV vaccine for all adults aged 75 and older and for adults aged 50 to 74 at increased risk of severe RSV disease; current evidence does not support repeat doses. Pregnant women can receive a maternal RSV vaccine at 32 to 36 weeks during September through January, or the infant can receive a long-acting monoclonal antibody in the first RSV season if under eight months, with a second-season dose for high-risk children aged 8 to 19 months. The NHS offers RSV vaccination to adults aged 75 to 79 and to pregnant women from 28 weeks.

Flu and COVID-19 vaccines can be given at the same visit. Whether RSV vaccination fits your situation is a conversation to have with your clinician, who can weigh your age, pregnancy status and health conditions against current guidance.

Common myths about flu vs covid vs RSV, corrected

“COVID-19 is just a cold now.” For many vaccinated, healthy adults, it does feel like one. For adults over 65 and people with chronic illness, COVID-19 still causes more hospitalizations than flu in many weeks of the year, and long-lasting symptoms after infection remain a documented risk. Mild for most is not the same as mild for all.

“If you have a high fever it must be flu, not COVID.” High fever is more typical of flu, but COVID-19 can produce fevers over 103°F, and flu can run with little fever in older adults. Fever height shifts the odds; it never confirms the virus.

“No loss of smell means it’s not COVID.” Loss of smell now occurs in a minority of COVID-19 cases. Its absence tells you very little.

“A negative home test rules it out.” Antigen tests miss early infections. A single negative in someone with symptoms should be repeated after two days, and a PCR test is more definitive.

“RSV only affects babies.” RSV sends 100,000 to 160,000 adults aged 65 and over to hospital in the United States each year and is a frequent trigger of worsening heart failure and COPD.

“Antibiotics will clear it up faster.” Antibiotics act on bacteria and have no effect on viruses. They are reserved for confirmed or strongly suspected bacterial complications such as pneumonia or ear infection.

“Vitamin C and zinc prevent or shorten these infections.” Systematic reviews reported by the NIH Office of Dietary Supplements find inconsistent results, with any effect on cold duration being small and no convincing benefit for flu or COVID-19.

“You can’t catch two at once.” Co-infection with flu and COVID-19, or RSV and either, is uncommon but well documented, and tends to be more severe. Multiplex PCR panels exist partly for this reason.

When to see a doctor: red-flag signs for flu, COVID-19 and RSV

Most cases of all three infections are managed at home. The following signs mean the illness has moved beyond home care and need same-day medical assessment or emergency services.

In adults, seek urgent care or call emergency services for:

• Difficulty breathing, shortness of breath at rest, or a blood oxygen reading persistently below 92 percent
• Chest pain or pressure that does not ease
• Confusion, new drowsiness, or difficulty staying awake
• Bluish or gray lips, face or nail beds
• Fever or cough that improves and then returns worse, a classic sign of secondary bacterial pneumonia
• Inability to keep fluids down, no urination for 8 hours or more, or severe dizziness on standing
• Seizures, or severe muscle pain and weakness that makes walking difficult

In infants and children, seek urgent care for:

• Fast breathing, grunting, ribs or nostrils pulling in with each breath, or pauses in breathing
• Wheezing in a baby under one year, particularly if feeding is poor
• Fewer wet diapers than usual, no tears when crying, or a dry mouth
• Any fever in a baby under 3 months, or fever above 104°F in older children
• Unusual limpness, inconsolable irritability, or a child who is hard to wake
• Blue or gray skin or lips

Contact a clinician the same day, even without red flags, if you are in a higher-risk group: aged 65 or older, pregnant, immunocompromised, or living with heart, lung, kidney, liver or metabolic disease, or if you care for an infant under six months who develops cold symptoms. These are the people for whom early testing and timely antiviral treatment make the biggest measurable difference, and the window is short.

Never stop or adjust any prescribed medicine because of a viral illness without speaking to the prescriber; some medicines for heart conditions, diabetes and immune disorders need specific handling during infection, and that guidance belongs to the clinician who knows your history.

Frequently asked questions

What are the current symptoms of COVID-19?

The most commonly reported symptoms with current variants are sore throat, nasal congestion or runny nose, cough, headache, fatigue and fever, often arriving gradually over one to three days. Hoarseness, muscle aches, nausea and diarrhea occur in a meaningful share of cases. Loss of taste or smell, once a hallmark, now affects a minority. Because this list overlaps heavily with flu and colds, a test is the only reliable way to confirm it.

How contagious is flu A, and for how long?

Seasonal influenza A spreads from about one day before symptoms begin until roughly five to seven days afterward in healthy adults, and longer in children and people with weakened immune systems. Each case infects a little more than one other person on average, but the short incubation period of one to four days makes outbreaks move quickly through households, classrooms and workplaces. Staying home while feverish and for 24 hours after it resolves limits spread.

How are covid symptoms vs flu symptoms different in the first day?

Flu usually begins abruptly with high fever, chills, headache and severe body aches within hours. COVID-19 more often starts with a scratchy throat, congestion or headache and builds over a couple of days before fever and cough appear. These are tendencies drawn from population data, not rules; studies find no symptom combination accurate enough to separate the two in an individual, so a combination home test is the practical next step.

What are rsv vs covid symptoms in adults?

In adults, RSV typically looks like a heavy cold with congestion, thick mucus, cough and low-grade fever, and in older adults it often shows up as a sudden worsening of existing heart or lung disease with wheezing. COVID-19 more often brings sore throat, headache, body aches, fatigue and sometimes diarrhea or loss of smell. Both can cause breathlessness, and only a laboratory test can tell them apart with confidence.

Is there a single flu covid rsv test I can take?

Yes, in clinics and hospitals. Multiplex PCR panels detect influenza A and B, SARS-CoV-2 and RSV from one nasal swab, usually within hours. Home kits currently cover flu A, flu B and COVID-19 together, but RSV home testing is not yet widely available. For a healthy adult the home kit answers the two questions that change treatment; for an infant or an older adult with wheeze, a clinic test is more appropriate.

What are some home remedies for managing symptoms of COVID-19 or the flu?

Fluids, rest, and over-the-counter fever reducers used as the label directs cover most needs. Honey helps night-time cough in children over one year, saline nasal sprays ease congestion, and warm liquids soothe a sore throat. Steam or a humidifier can loosen mucus. None of these shortens the infection; they manage symptoms. Antibiotics, high-dose vitamin C and zinc have no proven benefit, and aspirin should never be given to children during a viral illness.

Does Theraflu help with COVID?

Combination cold and flu products relieve symptoms such as fever, aches, congestion and cough regardless of which virus is responsible, so they can make a person with COVID-19 more comfortable. They do not act on the virus or shorten the illness. Check ingredients carefully to avoid doubling up on the same fever reducer, be cautious with decongestants if you have high blood pressure, and ask a pharmacist or clinician if you take other medicines.

Can you have flu and COVID at the same time?

Yes. Co-infection with influenza and SARS-CoV-2 is uncommon but well documented, and studies of hospitalized patients suggest it tends to be more severe than either infection alone. RSV can also occur alongside either virus, particularly in young children. This is one reason clinicians use multiplex tests that check for several viruses at once, and one reason annual vaccination against both flu and COVID-19 is recommended for higher-risk groups.

How long should I stay home with flu, COVID-19 or RSV?

CDC guidance for respiratory viruses advises staying home until symptoms are improving overall and you have been fever-free for at least 24 hours without fever-reducing medicine. For the following five days, extra precautions such as masking, distancing and good ventilation reduce the chance of passing the virus on, since people can remain contagious after they feel better. Infants and immunocompromised people may shed RSV for several weeks.

Who should get the RSV vaccine?

The CDC recommends a single RSV vaccine dose for all adults aged 75 and older and for adults aged 50 to 74 who are at increased risk of severe RSV disease, such as those with chronic heart or lung conditions or weakened immunity. Pregnant women can receive a maternal RSV vaccine at 32 to 36 weeks between September and January to protect the newborn. Your clinician can confirm whether you fit current eligibility.

References

• CDC: Similarities and Differences between Flu and COVID-19
• CDC: RSV Vaccines
• NHS: Flu
• MedlinePlus: Respiratory Syncytial Virus Infections

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.